2026-2030年全球止血診斷市場

全球止血診斷市場預計將從 2025 年到 2030 年成長至 11.336 億美元，預測期內複合年成長率為 7.2%。

本報告對全球止血診斷市場進行了全面分析，包括市場規模和預測、趨勢、成長要素、挑戰以及涵蓋約 25 家供應商的供應商分析。

本報告對當前市場狀況、最新市場趨勢和促進因素以及整體市場環境進行了最新分析。該市場的成長主要受以下因素驅動：凝血障礙和心血管疾病盛行率的上升、抗凝血治療的日益普及、疾病監測需求的成長，以及醫療基礎設施和診斷檢測網路的擴展。

本研究客觀地結合了一手和二手訊息，包括來自主要行業相關人員的信息。報告內容涵蓋主要公司分析、全面的市場規模資料、細分市場資訊及區域分析，以及供應商格局。報告包含歷史數據和預測數據。

這項研究表明，對個人化凝血評估方法的日益重視將成為未來幾年全球止血診斷市場成長的主要驅動力之一。此外，隨著檢查室工作流程中數位化連接的整合以及分散式和患者側血液凝固檢驗的普及，預計市場需求將顯著成長。

目錄

第1章：執行摘要

第2章 Technavio 分析

• 分析定價、生命週期、顧客購買籃子、採用率和購買標準。
• 輸入的重要性及差異化因素
• 干擾因素
• 促進因素和挑戰的影響

第3章 市場狀況

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場的定義
• 市場區隔分析
• 2025年市場規模
• 市場展望，2025-2030年

第5章 市場規模與表現

• 2020-2024年全球止血診斷市場
• 2020年至2024年最終用戶細分市場分析
• 產品類型細分市場分析，2020-2024 年
• 2020年至2024年基於細分市場的分析
• 區域區隔市場分析，2020-2024 年
• 2020-2024年各國細分市場分析

第6章 定性分析

• 人工智慧的影響：全球止血診斷市場
• 地緣政治衝突的影響：全球止血診斷市場

第7章：五力分析

第8章 市場區隔：依最終用戶分類

• 比較：按最終用戶
• 醫院和診所
• 獨立診斷中心
• 研究和學術機構
• 市場機會：依最終用戶分類

第9章 市場區隔：依產品類型

• 比較：依產品類型
• 消耗品
• 分析器
• POCT系統
• 市場機會：依產品類型分類

第10章 透過檢驗進行市場區隔

• 測試比較
• PT
• APTT
• D-二聚體檢測
• 其他
• 透過檢驗方法所獲得的市場機會

第11章 客戶情況

第12章 區域情勢

• 區域細分
• 區域比較
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
• 亞洲
  • 中國
  • 日本
  • 韓國
  • 印度
  • 新加坡
  • 台灣
• 世界其他地區（RoW）
  • 巴西
  • 澳洲
  • 沙烏地阿拉伯
  • 以色列
  • UAE
  • 南非
  • 阿根廷
  • 哥倫比亞
• 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第14章 競爭格局

• 概述
• 競爭格局
• 混亂局面
• 產業風險

第15章 競爭分析

• 公司簡介
• 公司排名指標
• 企業市場定位
• Erba Mannheim
• F. Hoffmann La Roche Ltd.
• Haemonetics Corp.
• HORIBA Ltd.
• HUMAN Diagnostics Worldwide
• Maccura Biotechnology Co. Ltd.
• Sekisui Diagnostics LLC
• Shenzhen Mindray Co. Ltd.
• Siemens Healthineers AG
• Sysmex Corp.
• Technoclone GmbH
• TECO Medical Instruments
• Tulip Diagnostics Pvt. Ltd.
• Werfenlife SA
• Zybio Inc.

第16章附錄

The global hemostasis diagnostics market is forecasted to grow by USD 1133.6 mn during 2025-2030, accelerating at a CAGR of 7.2% during the forecast period. The report on the global hemostasis diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of coagulation disorders and cardiovascular conditions, increasing adoption of anticoagulant therapies and disease monitoring requirements, expansion of healthcare infrastructure and diagnostic laboratory networks.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global hemostasis diagnostics market is segmented as below:

By End-User

• Hospitals and clinics
• Independent diagnostic centers
• Research and academic institutions

By Product Type

• Consumables
• Analyzers
• POCT systems

By Test

• PT
• APTT
• D-dimer test
• Others

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the growing focus on personalized coagulation assessment approaches as one of the prime reasons driving the global hemostasis diagnostics market growth during the next few years. Also, increasing integration of digital connectivity within laboratory workflows and growing adoption of decentralized and near-patient coagulation testing will lead to sizable demand in the market.

The report on the global hemostasis diagnostics market covers the following areas:

• Global hemostasis diagnostics market sizing
• Global hemostasis diagnostics market forecast
• Global hemostasis diagnostics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global hemostasis diagnostics market vendors that include Beijing Succeeder Technology, Biomedica Diagnostics Inc., DIAGNOSTICA STAGO SAS, DIAGON Kft., Erba Mannheim, F. Hoffmann La Roche Ltd., Haemonetics Corp., HORIBA Ltd., HUMAN Diagnostics Worldwide, LABiTec, Maccura Biotechnology Co. Ltd., Sekisui Diagnostics LLC, Shenzhen Mindray Co. Ltd., Siemens Healthineers AG, Sysmex Corp., Technoclone GmbH, TECO Medical Instruments, Tulip Diagnostics Pvt. Ltd., Werfenlife SA, Zybio Inc.. Also, the global hemostasis diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Product Type
  • Executive Summary - Chart on Market Segmentation by Test
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Hemostasis Diagnostics Market 2020 - 2024
  • Historic Market Size - Data Table on Global Hemostasis Diagnostics Market 2020 - 2024 ($ million)
• 5.2 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.3 Product Type segment analysis 2020 - 2024
  • Historic Market Size - Product Type Segment 2020 - 2024 ($ million)
• 5.4 Test segment analysis 2020 - 2024
  • Historic Market Size - Test Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global hemostasis diagnostics market
• 6.2 Impact of geopolitical conflicts on global hemostasis diagnostics market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by End-user

• 8.1 Market segments
• 8.2 Comparison by End-user
• 8.3 Hospitals and clinics - Market size and forecast 2025-2030
• 8.4 Independent diagnostic centers - Market size and forecast 2025-2030
• 8.5 Research and academic institutions - Market size and forecast 2025-2030
• 8.6 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

9 Market Segmentation by Product Type

• 9.1 Market segments
• 9.2 Comparison by Product Type
• 9.3 Consumables - Market size and forecast 2025-2030
• 9.4 Analyzers - Market size and forecast 2025-2030
• 9.5 POCT systems - Market size and forecast 2025-2030
• 9.6 Market opportunity by Product Type
  • Market opportunity by Product Type ($ million)

10 Market Segmentation by Test

• 10.1 Market segments
• 10.2 Comparison by Test
• 10.3 PT - Market size and forecast 2025-2030
• 10.4 APTT - Market size and forecast 2025-2030
• 10.5 D-dimer test - Market size and forecast 2025-2030
• 10.6 Others - Market size and forecast 2025-2030
• 10.7 Market opportunity by Test
  • Market opportunity by Test ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 South Korea - Market size and forecast 2025-2030
  • 12.5.4 India - Market size and forecast 2025-2030
  • 12.5.5 Singapore - Market size and forecast 2025-2030
  • 12.5.6 Taiwan - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Australia - Market size and forecast 2025-2030
  • 12.6.3 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.4 Israel - Market size and forecast 2025-2030
  • 12.6.5 UAE - Market size and forecast 2025-2030
  • 12.6.6 South Africa - Market size and forecast 2025-2030
  • 12.6.7 Argentina - Market size and forecast 2025-2030
  • 12.6.8 Colombia - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Rising prevalence of coagulation disorders and cardiovascular conditions
  • Increasing adoption of anticoagulant therapies and disease monitoring requirements
  • Expansion of healthcare infrastructure and diagnostic laboratory networks
• 13.2 Market challenges
  • Limited standardization across coagulation testing platforms and methodologies
  • Stringent government regulations
  • Lack of awareness regarding hemostasis disorders in under-developed regions
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Growing focus on personalized coagulation assessment approaches
  • Increasing integration of digital connectivity within laboratory workflows
  • Growing adoption of decentralized and near-patient coagulation testing

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Erba Mannheim
  • Erba Mannheim - Overview
  • Erba Mannheim - Product / Service
  • Erba Mannheim - Key offerings
  • SWOT
• 15.5 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 15.6 Haemonetics Corp.
  • Haemonetics Corp. - Overview
  • Haemonetics Corp. - Business segments
  • Haemonetics Corp. - Key offerings
  • Haemonetics Corp. - Segment focus
  • SWOT
• 15.7 HORIBA Ltd.
  • HORIBA Ltd. - Overview
  • HORIBA Ltd. - Business segments
  • HORIBA Ltd. - Key offerings
  • HORIBA Ltd. - Segment focus
  • SWOT
• 15.8 HUMAN Diagnostics Worldwide
  • HUMAN Diagnostics Worldwide - Overview
  • HUMAN Diagnostics Worldwide - Product / Service
  • HUMAN Diagnostics Worldwide - Key offerings
  • SWOT
• 15.9 Maccura Biotechnology Co. Ltd.
  • Maccura Biotechnology Co. Ltd. - Overview
  • Maccura Biotechnology Co. Ltd. - Product / Service
  • Maccura Biotechnology Co. Ltd. - Key offerings
  • SWOT
• 15.10 Sekisui Diagnostics LLC
  • Sekisui Diagnostics LLC - Overview
  • Sekisui Diagnostics LLC - Product / Service
  • Sekisui Diagnostics LLC - Key offerings
  • SWOT
• 15.11 Shenzhen Mindray Co. Ltd.
  • Shenzhen Mindray Co. Ltd. - Overview
  • Shenzhen Mindray Co. Ltd. - Business segments
  • Shenzhen Mindray Co. Ltd. - Key offerings
  • Shenzhen Mindray Co. Ltd. - Segment focus
  • SWOT
• 15.12 Siemens Healthineers AG
  • Siemens Healthineers AG - Overview
  • Siemens Healthineers AG - Business segments
  • Siemens Healthineers AG - Key offerings
  • Siemens Healthineers AG - Segment focus
  • SWOT
• 15.13 Sysmex Corp.
  • Sysmex Corp. - Overview
  • Sysmex Corp. - Business segments
  • Sysmex Corp. - Key news
  • Sysmex Corp. - Key offerings
  • Sysmex Corp. - Segment focus
  • SWOT
• 15.14 Technoclone GmbH
  • Technoclone GmbH - Overview
  • Technoclone GmbH - Product / Service
  • Technoclone GmbH - Key offerings
  • SWOT
• 15.15 TECO Medical Instruments
  • TECO Medical Instruments - Overview
  • TECO Medical Instruments - Product / Service
  • TECO Medical Instruments - Key offerings
  • SWOT
• 15.16 Tulip Diagnostics Pvt. Ltd.
  • Tulip Diagnostics Pvt. Ltd. - Overview
  • Tulip Diagnostics Pvt. Ltd. - Product / Service
  • Tulip Diagnostics Pvt. Ltd. - Key offerings
  • SWOT
• 15.17 Werfenlife SA
  • Werfenlife SA - Overview
  • Werfenlife SA - Product / Service
  • Werfenlife SA - Key offerings
  • SWOT
• 15.18 Zybio Inc.
  • Zybio Inc. - Overview
  • Zybio Inc. - Product / Service
  • Zybio Inc. - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations